Kenya vs Uganda: HIV/AIDS deaths averted by antiretroviral therapy
Kenya
75,293 deaths
in 2024
Uganda
82,921 deaths
in 2024
Kenya rank
8th
Uganda rank
6th
HIV/AIDS deaths averted by antiretroviral therapy over time
- Kenya
- Uganda
How they compare
Uganda currently reports 82,921 deaths against 75,293 deaths in Kenya, a difference of 7,628 deaths.
That makes Uganda's figure about 1.1 times Kenya's.
The two have swapped places 4 times across 35 shared years of data; in 1990 it was Uganda ahead.
Kenya ranks 8th and Uganda ranks 6th of 157 countries.
Across the 4 decades both report, Kenya averaged higher in 2 and Uganda in 1.
Head to head by decade
| Decade | Kenya | Uganda | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 0 deaths | 0 deaths | 0 deaths | — |
| 2000s | 18,197 deaths | 12,859 deaths | 5,338 deaths | Kenya |
| 2010s | 71,552 deaths | 56,072 deaths | 15,480 deaths | Kenya |
| 2020s | 75,330 deaths | 81,329 deaths | 5,999 deaths | Uganda |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv/aids deaths averted by antiretroviral therapy, Kenya or Uganda?
- Uganda, at 82,921 deaths against 75,293 deaths in Kenya as of 2024.
- What is the difference in hiv/aids deaths averted by antiretroviral therapy between Kenya and Uganda?
- 7,628 deaths, with Uganda ahead.
- How many years of comparable data are there for Kenya and Uganda?
- 35 years are reported by both, from 1990 to 2024.
- How do Kenya and Uganda rank globally for hiv/aids deaths averted by antiretroviral therapy?
- Kenya ranks 8th and Uganda ranks 6th of 157 countries.
- Where does this data come from?
- Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data, published as HIV/AIDS deaths averted by antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths prevented as a direct result of Antiretroviral Therapy (ART) among people living with HIV. It is calculated by comparing the observed mortality rates in individuals receiving ART to the estimated mortality rates in the absence of such treatment. This is the central estimate.